Shanghai, China – 6 July, 2015 – Shanghai MicroPort Orthopedics Co ("MicroPort® Orthopedics") recently received the registration certificates from China Food and Drug Administration ("CFDA") for its Femoral Head Biolox Delta Ceramic and Rim-Lock Biolox Delta Ceramic Liner. With their market launch, MicroPort® Orthopedics will offer better options to surgeons and patients.
Compared to metal products, the biggest advantages of ceramic products is to reduce wear debris, increase prosthesis survivorship, lower the risks of inflammation and prosthesis dislocation. As the fourth generation of MicroPort® Orthopedics' ceramic products, Femoral Head Biolox Delta Ceramic and Rim-Lock Biolox Delta Ceramic Liner are built on the basis of the third generation Forte Ceramic products with zirconium added to make the material stronger and cracking resistant.
The Biolox ceramic material used in Femoral Head Biolox Delta Ceramic and Rim-Lock Biolox Delta Ceramic Liner has been used to make hip reconstruction products for over 40 years. The material features excellent biocompatibility and scratch resistance to bone cement particles. With its outstanding wettability, it can form effective liquid film lubrication to reduce friction and wear. Up to date, more than 10 million joint prostheses made of Biolox ceramic material have been implanted worldwide.